Why the study?
Does carriership of the prothrombin 20210A mutation increase the risk of first VTE or arterial cardiovascular event in asymptomatic first-degree relatives?
Population
464 asymptomatic first-degree family members of patients with either VTE or premature atherosclerosis and…
Comparison
Carriers of the prothrombin 20210A mutation vs Noncarriers of the prothrombin 20210A mutation
Design
Cohort
Follow-up
Total 1816 patient-years (943 years for carriers)
Authors
Loading...
Low absolute risks with wide CIs in asymptomatic relatives; leaves open whether prothrombin 20210A testing alters management or warrants larger studies.
Does carriership of the prothrombin 20210A mutation increase the risk of first VTE or arterial cardiovascular event in asymptomatic first-degree relatives?
The absolute incidence of VTE or arterial cardiovascular events is low in asymptomatic carriers of the prothrombin 20210A mutation, suggesting routine testing of first-degree relatives is not justified.
Coppens et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: